Kadmon Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KADMON PHARMS LLC, and what generic alternatives to KADMON PHARMS LLC drugs are available?
KADMON PHARMS LLC has one approved drug.
There are five US patents protecting KADMON PHARMS LLC drugs.
There are forty-two patent family members on KADMON PHARMS LLC drugs in twenty-seven countries and one supplementary protection certificate in one country.
Summary for Kadmon Pharms Llc
International Patents: | 42 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Kadmon Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 8,357,693 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 11,311,541 | ⤷ Sign Up | ⤷ Sign Up | ||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 10,183,931 | ⤷ Sign Up | ⤷ Sign Up | ||||
Kadmon Pharms Llc | REZUROCK | belumosudil mesylate | TABLET;ORAL | 214783-001 | Jul 16, 2021 | RX | Yes | Yes | 10,696,660 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kadmon Pharms Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 113620933 | ⤷ Sign Up |
Poland | 2903618 | ⤷ Sign Up |
European Patent Office | 2903618 | ⤷ Sign Up |
China | 113773308 | ⤷ Sign Up |
Eurasian Patent Organization | 201500362 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kadmon Pharms Llc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2903618 | SPC/GB22/068 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: BELUMOSUDIL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK PLGB 53904/0001-0001 20220707 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.